U.S. Markets close in 6 hrs 28 mins

ImmunoCellular Therapeutics, Ltd. (IMUC)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.3346+0.0080 (+2.4495%)
As of 9:31AM EDT. Market open.
People also watch
NWBOGALEAEZSCLSNCUR
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development19,105.72710,896.5915,969.182
Selling General and Administrative5,006.3984,616.53,889.359
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-24,112.125-15,513.091-9,858.541
Income from Continuing Operations
Total Other Income/Expenses Net3,836.7792,945.121543.691
Earnings Before Interest and Taxes-20,275.346-12,567.97-9,314.85
Interest Expense1,810.356222.84462.683
Income Before Tax-22,085.702-12,790.814-9,377.533
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-22,085.702-12,790.814-9,377.533
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-22,085.702-12,790.814-9,377.533
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-22,085.702-12,790.814-9,377.533